Hensin Tsao
Hensin Tsao
Professor, Harvard Medical School
Verified email at
Cited by
Cited by
Management of cutaneous melanoma
H Tsao, MB Atkins, AJ Sober
New England Journal of Medicine 351 (10), 998-1012, 2004
Selective BRAFV600E Inhibition Enhances T-Cell Recognition of Melanoma without Affecting Lymphocyte Function
A Boni, AP Cogdill, P Dang, D Udayakumar, CNJ Njauw, CM Sloss, ...
Cancer research 70 (13), 5213-5219, 2010
Melanoma: from mutations to medicine
H Tsao, L Chin, LA Garraway, DE Fisher
Genes & development 26 (11), 1131-1155, 2012
Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma
H Tsao, G Yang, V Goel, H Wu, FG Haluska
Journal of Investigative Dermatology 122 (2), 337-341, 2004
Guidelines of care for the management of primary cutaneous melanoma
SM Swetter, H Tsao, CK Bichakjian, C Curiel-Lewandrowski, DE Elder, ...
Journal of the American Academy of Dermatology 80 (1), 208-250, 2019
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
S Yokoyama, SL Woods, GM Boyle, LG Aoude, S MacGregor, V Zismann, ...
Nature 480 (7375), 99-103, 2011
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
AM Goldstein, M Chan, M Harland, NK Hayward, F Demenais, DT Bishop, ...
Journal of medical genetics 44 (2), 99-106, 2007
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
AM Goldstein, M Chan, M Harland, EM Gillanders, NK Hayward, MF Avril, ...
Cancer research 66 (20), 9818-9828, 2006
Guidelines of care for the management of primary cutaneous melanoma
CK Bichakjian, AC Halpern, TM Johnson, AF Hood, JM Grichnik, ...
Journal of the American Academy of Dermatology 65 (5), 1032-1047, 2011
A two-stage, p16INK4A-and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status
JG Rheinwald, WC Hahn, MR Ramsey, JY Wu, Z Guo, H Tsao, M De Luca, ...
Molecular and cellular biology, 2002
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
U McDermott, SV Sharma, L Dowell, P Greninger, C Montagut, J Lamb, ...
Proceedings of the National Academy of Sciences 104 (50), 19936-19941, 2007
Cutaneous melanomas associated with nevi
C Bevona, W Goggins, T Quinn, J Fullerton, H Tsao
Archives of dermatology 139 (12), 1620-1624, 2003
The transformation rate of moles (melanocytic nevi) into cutaneous melanoma: a population-based estimate
H Tsao, C Bevona, W Goggins, T Quinn
Archives of dermatology 139 (3), 282-288, 2003
Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants
T Hocker, H Tsao
Human mutation 28 (6), 578-588, 2007
The skin microbiome: current perspectives and future challenges
YE Chen, H Tsao
Journal of the American Academy of Dermatology 69 (1), 143-155. e3, 2013
Identification of PTEN/MMAC1 alterations in uncultured melanomas and melanoma cell lines
H Tsao, X Zhang, E Benoit, FG Haluska
Oncogene 16 (26), 3397-3402, 1998
Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines
H Tsao, X Zhang, K Fowlkes, FG Haluska
Cancer research 60 (7), 1800-1804, 2000
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families
CNJ Njauw, I Kim, A Piris, M Gabree, M Taylor, AM Lane, MM DeAngelis, ...
PloS one 7 (4), e35295, 2012
Melanoma genetics and therapeutic approaches in the 21st century: moving from the benchside to the bedside
TL Hocker, MK Singh, H Tsao
Journal of Investigative Dermatology 128 (11), 2575-2595, 2008
Genetic alterations in signaling pathways in melanoma
FG Haluska, H Tsao, H Wu, FS Haluska, A Lazar, V Goel
Clinical cancer research 12 (7), 2301s-2307s, 2006
The system can't perform the operation now. Try again later.
Articles 1–20